Abstract
BackgroundResearchers are increasingly motivated to move toward patient-centric drug development. TransCelerate has identified improved “information exchange” as an important component of creating a more satisfying clinical trial experience for patients and their health care professionals (HCPs).MethodsPatients, sponsors, sites, and HCPs were engaged through surveys, interviews, and/or advisory boards to capture the current status of information exchange and identify possible future practices between the major stakeholders within the clinical research ecosystem.ResultsData suggest that patients have numerous desires and preferences for information exchange during their clinical trial journey that are not commonly met. Various opportunities exist to improve the clinical trial participants’ experiences by improving information exchange practices across various stages of the participant’s journey.ConclusionsA shift in industry focus toward more comprehensive information exchange with trial participants has the potential to positively impact many patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
